University of California, San Francisco
San Francisco, California, 94143, United States
Location status: Recruiting
Location contact
Patricia Murphy, RN
CONTACT
Robert Goldsby, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05641961
This clinical trial studies the effectiveness of a newly developed survivorship mobile application (app) designed for survivors, or their caregivers, of childhood cancer to help them better navigate long-term follow-up care. The survivorship app provides survivors access to their treatment history and follow-up recommendations, improves knowledge of their diagnosis, treatment, risks, and recommended follow-up care by using a message notification. The ability to quickly connect and establish care planning may enhance adherence to recommended follow-up.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
San Francisco, California, 94143, United States
Location status: Recruiting
Patricia Murphy, RN
CONTACT
Robert Goldsby, MD
PRINCIPAL_INVESTIGATOR
PRIMARY OBJECTIVE:
I. To determine the difference in survivor/caregiver knowledge and understanding of diagnosis, treatment information, and follow-up needs using the survivorship app.
SECONDARY OBJECTIVE:
I. To validate the usability and effectiveness of the survivorship mobile application.
OUTLINE:
Participants are seen in the survivorship clinic and receive education about potential late effects and the survivorship application on study. Participants then use the survivorship app for 4 months on study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mobile phone application
Other names: Survivorship App
Questionnaires assessing cancer knowledge and system usability will be delivered to participants via Survivorship App
Time frame: Up to 4 months
The knowledge of the participant will be measured using a 12-item questionnaire that assesses the awareness of their treatment and health issues in four categories: (1) diagnosis, (2) treatment, (3) risks, and (4) recommended follow-up. A scoring system has been devised which will give a score to each questionnaire out of 100 possible points. The change in participants knowledge scores >=20 points from baseline will be reported.
Time frame: Up to 2 months
System Usability Scale (SUS) consists of a 10-item survey with five response options from Strongly agree to Strongly disagree. The scoring of positive questions is done as follows: The user's score is reduced by one point. For example, if the user's score is 4 for question 5, then the outcome score will be 3. The scoring of negative questions is done as follows: The user's score is subtracted from 5. For example, if the user's score is 3 for question 4, then the new score will be 2. After all the scores are determined, the sum of the scores is multiplied by 2.5 to make the range between 0 and 100. Scores above 68 are considered above average. The proportion of participants with an acceptable usability score > 68 will be reported.
Contact information is provided by the study sponsor or research team.
University of California, San Francisco
Other
Utilizing a Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06747910
Childhood Cancer, Hematologic Diseases
Memphis, Tennessee, United States
View Trial DetailsNCT03297034
Childhood Cancer, Neoplasms
Bern, Canton of Bern, Switzerland
View Trial DetailsNCT00684580
Childhood Cancer, Neoplasms
Memphis, Tennessee, United States
View Trial DetailsNCT05582551
Childhood Cancer, Ear Diseases
St Louis, Missouri, United States
View Trial Details